Income Statement Group
| | | |
(in € million) |
Notes |
2003 |
2004 |
Sales |
|
4,435 |
4,546 |
Cost of goods sold |
|
-1,584 |
-1,613 |
Gross profit | |
2,851 |
2,933 |
Marketing and selling expenses |
|
-2,025 |
-2,087 |
Research and development expenses |
|
-97 |
-101 |
General and administrative expenses |
|
-230 |
-233 |
Other operating income |
|
95 |
117 |
Other operating expenses |
|
-139 |
-146 |
Operating result (EBIT) | |
455 |
483 |
Result from equity investments (BSN medical) | |
18 |
22 |
Interest result |
|
20 |
-7 |
Other financial result |
|
-2 |
-6 |
Financial result | |
36 |
9 |
Profit before tax | |
491 |
492 |
Taxes on income |
|
-190 |
-190 |
Profit after tax | |
301 |
302 |
Minority interests |
|
-7 |
-6 |
Net profit | |
294 |
296 |
Earnings per share (in €) |
|
3.50 |
3.88 |
Diluted earnings per share (in €) |
|
3.50 |
3.88 | | | | | | | | | | |
 |
 |
We use leading-edge technologies to manufacture our products. |
|
 |
|